AbCellera Acquires TetraGenetics, Enhancing Capabilities to Generate Antibodies Against High-Value Targets
Go back to AbCellera Acquires TetraGenetics, Enhancing Capabilities to Generate Antibodies Against High-Value Targets| (NASDAQ: ABCL) | Delayed: 11.32 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $11.32 | 52 Week High | $ | |||
| Open | $11.32 | 52 Week Low | $ | |||
| Day High | $11.32 | P/E | N/A | |||
| Day Low | $11.32 | EPS | $ | |||
| Volume | 31,420 | |||||

